Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension Study to Investigate the Long Term Safety, Tolerability And Efficacy of Oral Monepantel in Individuals With Motor Neurone Disease Who Previously Completed Study MON-2021-001

NCT06177431 is registered in ClinicalTrials.gov with Neurizon Therapeutics Limited as lead sponsor.

NCT NCT06177431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06177431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension Study to Investigate the Long Term Safety, Tolerability And Efficacy of Oral Monepantel in Individuals With Motor Neurone Disease Who Previously Completed Study MON-2021-001
Lead sponsor
Neurizon Therapeutics Limited
Phase
Phase 1
Overall status
Completed
Start date
February 13, 2024
Completion date
May 30, 2025
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

motor neuron disease